Biotech grants in Germany
Explore Biotech grants for companies in Germany. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from German innovation agencies, research funders and foundations, EU and international programs open to applicants in Germany, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Germany come first.
Showing 313-336 of 668 grants
Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria - A Model for Mosquito-Borne Diseases
NIH · United States
Funds basic and preclinical research toward more effective malaria vaccines, designed as a model for other mosquito-borne diseases too.
Bridge2AI Network for AI Health Science
NIH · United States
Funds a network of centers that builds the methods to judge whether biomedical AI can actually be trusted.
A Holistic Approach to Study Non-Addictive Natural Products for Pain Management
NIH · United States
Funds mechanistic research into how non-addictive natural products actually relieve chronic pain, across the whole body.
Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL)
NIH · United States
Funds one renewed operator for AnVIL, the cloud platform holding more than 5 petabytes of genomic data for reproducible research.
Improved Drug Susceptibility Testing (DST) for Mycobacteria
NIH · United States
Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds early proof-of-concept work testing whether a new cancer research tool, assay, platform or instrument is technically feasible at all.
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the ongoing development, dissemination or upkeep of a cancer informatics tool that has already outgrown its prototype stage.
INCLUDE Project: Omics Phenotypes Related to Down Syndrome
NIH · United States
Funds access to genomic and multi-omics processing of Down syndrome biospecimens through NIH's INCLUDE Project, with no direct cash award.
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
NIH · United States
Funds small-molecule drug candidates from a lab bench through Phase I testing, with NIH's own chemistry and toxicology experts on call.
NIAMS Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
NIH · United States
Funds better drug dosing and safer medicines for pregnant women, lactating women, infants, children and adolescents.
Claude D. Pepper Older Americans Independence Centers
NIH · United States
Funds a center of excellence built around one chosen theme in helping older adults stay independent.
Clinical Trials in Organ Transplantation in Children and Adults
NIH · United States
Funds multicenter clinical trials, with mechanism studies, testing ways to improve outcomes across heart, lung, kidney, liver and gut transplants.
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier
NIH · United States
Funds mapping how nutrients, drugs and chemicals cross the placenta, gut, mammary gland and blood-brain barrier in pregnancy and infancy.
ancient DNA for Modern Genomics (aDMG) Research Projects
NIH · United States
Funds research using ancient human DNA data to understand the diseases and traits people carry today.
The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
NIH · United States
Funds the secure cloud platform that stores, harmonizes and shares Alzheimer's genetic and genomic data for the whole research community.
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
NIH · United States
Funds one of up to six clinical research centers studying disorders where the gut and nervous system miscommunicate, from gastroparesis to related conditions.
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
NIH · United States
Funds the single data coordinating center for NIDDK's inflammatory bowel disease genetics consortium, managing biospecimens and data from its research centers.
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
NIH · United States
Funds genomic research centres hunting the genetic and biological roots of inflammatory bowel disease.
NCI Research Specialist (Clinician Scientist) Award
NIH · United States
Funds salary support for a clinician scientist who leads and sustains NCI's clinical trials networks without being a grant's principal investigator.
Functional Target Validation for Alzheimer's Disease-Related Dementias
NIH · United States
Funds phased research proving a newly identified Alzheimer's-related dementia target truly causes the disease process it's linked to.
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
NIA · United States
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks
NIH · United States
Funds a multi-center clinical trial or ancillary study run inside an already-funded NIH Clinical Trial Research Network, in two milestone-driven phases.